期刊文献+

活性氧在糖尿病心肌病中的作用机制研究进展 被引量:15

Research progress on the mechanism of action of reactive oxygen species in diabetic cardiomyopathy
下载PDF
导出
摘要 糖尿病心肌病是由糖尿病引起的葡萄糖及脂质代谢紊乱,这些代谢紊乱又可增强氧化应激,激活各种炎症途径,介导细胞及细胞外损伤,从而造成病理性心肌重构,进而导致心脏舒张及收缩功能障碍。尽管目前已提出了关于糖尿病心肌病的几种病理生理机制,但其确切发病机制仍不完全清楚。氧化应激为该病的主要机制之一,其中活性氧的生成增多是引起不良心肌重构的主要机制。因此,该文将针对糖尿病心肌病中活性氧的主要来源(NADPH氧化酶、线粒体、解偶联eNOS及黄嘌呤氧化酶)及其介导的心肌损害(脂质过氧化、蛋白质氧化及DNA损害)进行综述。 Diabetic cardiomyopathy(DCM)is an metabolic disorder of glucose and lipids caused by diabetes,which may strengthen oxidative stress,activate various inflammatory pathways,mediate cellular and extracellular damage,so as to induce pathological myocardial remodeling and lead to systolic and diastolic dysfunction.The exact pathogenesis of DCM remains unclear in spite of several pathophysiological mechanism of DCM have been put forward.Oxidative stress is one of the main causes of DCM,in which the increased production of reactive oxygen species(ROS)is the main mechanism causing adverse myocardial remodeling.So,the main source of ROS in DCM[Nadph oxidase,mitochondria,endothelial nitric oxide synthase(eNOS),xanthine oxidase,(XO)]and the ROS-mediated myocardial damage(lipid peroxidation,protein oxidation and DNA damage)are summarized in present paper.
作者 郭振 樊迪 唐其柱 Guo Zhen;Fan Di;Tang Qi-Zhu(Department of Vasculocardiology,Renmin Hospital of Wuhan University,Wuhan 430060,China;Key Laboratory of Metabolism and Related Chronic Diseases of Hubei Province,Wuhan 430060,China)
出处 《解放军医学杂志》 CAS CSCD 北大核心 2020年第12期1294-1298,共5页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(81900219,81530012,81800216) 中央高校基本科研业务费专项资金项目(2042019kf0062,2042018kf1032) 国家重点研发项目(2018YFC1311300)。
关键词 糖尿病心肌病 氧化应激 活性氧 线粒体 diabetic cardiomyopathy oxidative stress reactive oxygen species mitochondria
  • 相关文献

参考文献2

二级参考文献50

  • 1Vijay Sharma,John H McNeill.Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze[J].World Journal of Cardiology,2011,3(9):281-302. 被引量:8
  • 2Pitchai Balakumar,Vishal Arvind Chakkarwar,Manjeet Singh.Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat[J]. Molecular and Cellular Biochemistry . 2009 (1-2)
  • 3Ewa Konduracka,Grazyna Cieslik,Danuta Galicka-Latala,Pawel Rostoff,Artur Pietrucha,Pawel Latacz,Grzegorz Gajos,Maciej T. Malecki,Jadwiga Nessler.Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study[J]. Acta Diabetologica . 2013 (4)
  • 4Takayuki Miki,Satoshi Yuda,Hidemichi Kouzu,Tetsuji Miura.Diabetic cardiomyopathy: pathophysiology and clinical features[J]. Heart Failure Reviews . 2013 (2)
  • 5Ronald M. Witteles,Khun Visith Keu,Andrew Quon,Homa Tavana,Michael B. Fowler.Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy[J]. Journal of Cardiac Failure . 2012 (10)
  • 6Falah Aboukhoudir,Sofiene Rekik.Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach[J]. The International Journal of Cardiovascular Imaging . 2012 (6)
  • 7Peng Zhao,Jie Zhang,Xian-Gang Yin,Preben Maharaj,Sharmain Narraindoo,Lian-Qun Cui,Yuan-Sheng Tang.The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy[J]. Life Sciences . 2012
  • 8Zehra Hashim,Shamshad Zarina.Osmotic stress induced oxidative damage: Possible mechanism of cataract formation in diabetes[J]. Journal of Diabetes and Its Complications . 2012 (4)
  • 9Guoguang Wang,Wei Li,Xiaohua Lu,Pengju Bao,Xue Zhao.Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy[J]. Journal of Diabetes and Its Complications . 2012 (4)
  • 10Elisa Giannetta,Andrea M. Isidori,Nicola Galea,Iacopo Carbone,Elisabetta Mandosi,Carmine D. Vizza,Fabio Naro,Susanna Morano,Francesco Fedele,Andrea Lenzi.Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging[J]. Circulation . 2012 (19)

共引文献110

同被引文献172

引证文献15

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部